论文部分内容阅读
豪夫迈·罗氏公司和上海新亚药业公司历经3年的艰苦谈判,由双方共同投资在上海浦东新区兴建的维生素B_6生产企业——罗氏新亚(上海)维生素有限公司于日前正式签约。公司竣工投产后预计年产维生素B_61000吨。双方总投资额为2960万美元。罗氏和新亚分别占60％和40％。合资后,双方将使用国际先进技术,扬长避短,优化现行的维生素B_6生产路线,引进先进的检测手段和
After three years of hard negotiations, Hafmar Roche and Shanghai New Asia Pharmaceutical Co., Ltd. signed a contract with Roche New Asia (Shanghai) Vitamin Co., Ltd., a vitamin B6 manufacturer that was jointly invested in Shanghai Pudong New Area. After the company is completed and put into operation, it is expected to produce an annual output of vitamin B 61,000 tons. The total investment of the two parties is 29.6 million US dollars. Roche and Xinya account for 60% and 40% respectively. After the joint venture, the two parties will use international advanced technology to avoid weaknesses, optimize the current vitamin B6 production route, and introduce advanced testing methods.